8MK-21315-73405
4 vaccinations
5 coded responses
26 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 947 / CA
- Registered
- 2021-03-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-05
Dose 1 — Pfizer-BioNTech
-
2021-03-26
Dose 2 — Pfizer-BioNTech
-
2021-03-27
Registered in v-safe
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-28
- 2021-03-29
-
2021-03-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache · Be unable to workAdult check-in
- 2021-04-01
- 2021-04-02
- 2021-04-09
- 2021-04-16
-
2021-04-23
Survey response — day 28, dose 2MedDRA: Ovarian cyst ruptured — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Ruptured ovarian cystMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-23
Report sent to call center — day 28, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-30
- 2021-05-07
-
2021-06-27
Survey response — 3 months, dose 2MedDRA: Capillary leak syndrome, Joint swelling, Office visit — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Swelling in right/foot ankle. Evaluated and no blood clot. Doctor says leaky blood vessels.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-27
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-28
-
2021-06-29
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-09-24
-
2021-11-30
Dose 3 — Pfizer-BioNTech
- 2022-03-26
-
2022-09-08
Dose 4 — Pfizer-BioNTech
-
2022-09-10
Survey response — days 1–6 daily, dose 4MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-09-11
Survey response — days 1–6 daily, dose 4MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-09-13
Survey response — days 1–6 daily, dose 4MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-09-14
- 2022-09-17
- 2022-09-22
- 2022-09-29
- 2022-10-06
- 2022-10-13
- 2022-10-22
- 2022-12-08
- 2023-03-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-05 | Pfizer-BioNTech | |
| 2 | 2021-03-26 | Pfizer-BioNTech | |
| 3 | 2021-11-30 | Pfizer-BioNTech | No |
| 4 | 2022-09-08 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 7 — day 28, dose 2
Symptoms: Ruptured ovarian cyst
Release 9 — 3 months, dose 2
Symptoms: Swelling in right/foot ankle. Evaluated and no blood clot. Doctor says leaky blood vessels.
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Sore throat
Systemic reaction (other): Sore throat
Systemic reaction (other): Sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Capillary leak syndrome | ✓ | ✓ | ✓ |
| SD | Joint swelling | ✓ | ✓ | ✓ |
| SD | Office visit | ✓ | ✓ | ✓ |
| SD | Ovarian cyst ruptured | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release